Other intracranial haemorrhages

I9_OTHINTRACRA

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I62 Cause of death: ICD-10 — I62 2 out of 7 registries used, show all original rules.	1124
4. Check minimum number of events None	1124
5. Include endpoints None	1124
6. Filter based on genotype QC (FinnGen only)	1124

Control definitions (FinnGen only)

Control exclude: I9_CEREBVASC

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: I60-I69
Name in latin: Alia haemorrhagia intracranialis non traumatica

NAME	I9_OTHINTRACRA
CONTROL_EXCLUDE	I9_CEREBVASC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I62
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I62
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other intracranial haemorrhages based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	10757	4015	6617
Only index persons	8357	3132	5225
Unadjusted period prevalence (%)
Whole population	0.16	0.12	0.18
Only index persons	0.17	0.12	0.20
Median age at first event (years)
Whole population	74.17	76.06	73.01
Only index persons	73.90	75.44	72.98

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1124	356	768
Unadjusted period prevalence (%)	0.27	0.12	0.34
Median age at first event (years)	72.47	69.31	73.94

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1013: Matched controls
10130

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

64.4

323.0

512

158

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

121.7

323.0

422

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

16384.0

323.0

770

I62.9

ICD-10 Finland

Intracranial haemorrhage (nontraumatic), unspecified

+∞

237.0

218

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

139.8

193.4

202

AA1AD

NOMESCO Finland

CT of head and brain

8.0

190.0

572

1414

I62.1

ICD-10 Finland

Nontraumatic extradural haemorrhage

+∞

115.9

109

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

58.9

110.0

129

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

+∞

76.0

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

3.6

75.4

490

2096

X59

ICD-10 Finland

Exposure to unspecified factor

4.4

74.4

321

958

W19

ICD-10 Finland

Unspecified fall

5.6

66.9

218

475

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

332.5

62.1

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

19.2

60.2

K90

ICPC

Stroke/cerebrovascular accident

29.2

59.7

AAD05

NOMESCO Finland

Evacuation of acute subdural haematoma

85.3

57.7

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

589.6

57.2

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

+∞

56.8

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

273.9

51.6

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

7.4

42.2

105

156

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.1

41.5

283

1140

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

+∞

40.9

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

+∞

40.9

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

413.0

40.4

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

413.0

40.4

N03AX14

ATC

levetiracetam; systemic

13.0

40.2

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

10.9

38.9

R51.80

ICD-10 Finland

Headache

3.7

35.2

168

512

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

+∞

33.5

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.8

31.4

230

948

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

25.1

29.4

AAF00

NOMESCO Finland

Ventriculostomy

58.5

29.3

G91.0

ICD-10 Finland

Communicating hydrocephalus

28.9

29.1

B01AA03

ATC

warfarin; systemic

2.3

29.0

356

1936

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

4.7

28.1

226

K91

ICPC

Cerebrovascular disease

23.1

28.0

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

277.9

26.8

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

99.4

26.8

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

+∞

26.1

G40.9

ICD-10 Finland

Epilepsy, unspecified

7.3

25.5

AAD12

NOMESCO Finland

Drainage of subdural fluid

51.4

25.3

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.1

25.0

377

2214

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

245.4

23.7

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

10.2

22.7

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.5

22.7

114

358

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.9

22.4

269

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

22.4

221

1057

R42

ICD-10 Finland

Dizziness and giddiness

2.2

21.7

263

1387

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

117.5

21.6

XA800

NOMESCO Finland

Neuropsychological investigation

7.8

21.6

T90.5

ICD-10 Finland

Sequelae of intracranial injury

11.5

21.6

WX002

NOMESCO Finland

Sedation and analgesia

2.3

21.5

243

1240

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.4

21.3

107

336

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

+∞

20.9

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

9.7

20.7

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

9.1

20.0

R53

ICD-10 Finland

Malaise and fatigue

2.2

19.3

238

1255

N02BE01

ATC

paracetamol; systemic, rectal

2.1

19.0

832

6979

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

19.0

658

5072

N03AF02

ATC

oxcarbazepine; oral

6.3

18.7

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

14.5

18.6

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.8

18.4

223

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

7.8

18.3

N03AB02

ATC

phenytoin; systemic

10.9

18.0

R41.0

ICD-10 Finland

Disorientation, unspecified

4.3

17.8

164

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

12.7

17.7

N03AG01

ATC

valproic acid; systemic, rectal

4.3

17.7

165

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

29.3

17.5

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.2

17.4

172

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

+∞

16.7

C07AB07

ATC

bisoprolol; oral

1.7

16.3

555

4152

N19

ICPC

Speech disorder

13.8

16.0

N18

ICPC

Paralysis/weakness

9.7

16.0

S06.0

ICD-10 Finland

Concussion

2.7

15.8

116

468

S06.3

ICD-10 Finland

Focal brain injury

8.5

15.8

AA1AA

NOMESCO Finland

Head X-ray examination

10.6

15.8

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

26.7

15.6

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

4.7

15.1

112

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.6

15.1

117

488

N05AH04

ATC

quetiapine; oral

2.3

15.0

146

685

R47.0

ICD-10 Finland

Dysphasia and aphasia

25.4

14.7

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

+∞

14.6

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

+∞

14.6

PA2AD

NOMESCO Finland

CT angiography of brain

43.1

14.1

R4120

NOMESCO Finland

Occupational therapy

3.6

14.0

182

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

13.9

202

1127

SPAT1216

SPAT

Assessment of functional ability

2.0

13.9

200

1111

N80

ICPC

Head injury other

6.7

13.6

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

+∞

13.6

S06.9

ICD-10 Finland

Intracranial injury, unspecified

16.4

13.5

WX110

NOMESCO Finland

Local anesthesy

1.6

13.3

567

4412

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.1

13.1

251

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

19.3

12.9

P20

ICPC

Memory disturbance

2.0

12.9

176

953

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

12.8

196

1110

H53.4

ICD-10 Finland

Visual field defects

7.3

12.8

SPAT1234

SPAT

Support of social functional capacity

2.8

12.6

300

R4150

NOMESCO Finland

Neuropsychological rehabilitation

70.7

12.6

SPAT1229

SPAT

Assessment of need for aid

2.4

12.6

110

488

G91.1

ICD-10 Finland

Obstructive hydrocephalus

20.3

12.5

N06AX11

ATC

mirtazapine; oral

1.7

12.3

279

1807

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.6

12.0

156

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

11.9

460

3448

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

47.2

11.9

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

9.1

11.8

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

5.3

11.7

I63.8

ICD-10 Finland

Other cerebral infarction

+∞

11.5

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

+∞

11.5

X58

ICD-10 Finland

Exposure to other specified factors

2.2

11.4

122

597

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

35.4

11.3

L28

ICPC

Limited function/disability (L)

1.9

11.1

191

1126

Y96.9

ICD-10 Finland

Unspecified type of accident

5.8

10.9

N05AX08

ATC

risperidone; systemic

2.3

10.6

100

461

I60.8

ICD-10 Finland

Other subarachnoid haemorrhage

+∞

10.4

TKC20

NOMESCO Finland

Catheterisation of bladder

2.3

10.4

458

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

10.4

188

1124

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

32.9

10.3

PA7BD

NOMESCO Finland

CT angiography of neck and brain

7.2

10.3

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.7

10.2

261

N05CF01

ATC

zopiclone; oral

1.6

10.1

339

2423

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

10.1

139

755

AA5PD

NOMESCO Finland

CT examination of brain pefusion

40.5

10.0

C09AA02

ATC

enalapril; systemic

1.7

9.9

240

1568

G40.10

ICD-10 Finland

Simple partial seizures

11.5

9.6

SPAT1053

SPAT

Memory test

1.7

9.5

215

1377

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

9.4

276

1900

I60.7

ICD-10 Finland

Subarachnoid haemorrhage from intracranial artery, unspecified

+∞

9.4

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

+∞

9.4

I62

ICD-10 Finland

Other nontraumatic intracranial haemorrhage

+∞

9.4

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

+∞

9.4

I60.3

ICD-10 Finland

Subarachnoid haemorrhage from posterior communicating artery

+∞

9.4

R11

ICD-10 Finland

Nausea and vomiting

2.4

9.4

345

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

21.9

9.4

WX892

NOMESCO Finland

Monitored bed care

2.3

9.3

381

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.8

8.9

206

WX882

NOMESCO Finland

High dependency care

3.5

8.9

117

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

18.8

8.9

FFW96

NOMESCO Finland

Other operation on atria

24.2

8.9

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

3.2

8.9

145

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

8.9

203

1300

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.0

8.7

159

N03AF01

ATC

carbamazepine; oral, rectal

2.7

8.6

224

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

8.6

309

2229

N05BA04

ATC

oxazepam; oral

1.6

8.5

221

1466

S01.0

ICD-10 Finland

Open wound of scalp

2.2

8.4

413

ABB40

NOMESCO Finland

Evacuation of spontaneous haematoma of spinal canal

90.7

8.4

AAD15

NOMESCO Finland

Evacuation of traumatic intracerebral haematoma

90.7

8.4

N29

ICPC

Neurological sympt/complt other

4.5

8.4

F05.9

ICD-10 Finland

Delirium, unspecified

3.7

8.4

A28

ICPC

Limited function/disability NOS

1.7

8.4

188

1198

AAL00

NOMESCO Finland

Endovascular occlusion of intracranial aneurysm

+∞

8.3

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

33.6

8.1

G41.9

ICD-10 Finland

Status epilepticus, unspecified

9.0

8.0

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.1

8.0

414

SPAT1254

SPAT

Administration of medicine

1.7

8.0

163

1007

C10AA01

ATC

simvastatin; oral

1.5

7.9

472

3783

R50.9

ICD-10 Finland

Fever, unspecified

1.8

7.8

137

808

G81.9

ICD-10 Finland

Hemiplegia, unspecified

9.5

7.8

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.1

7.7

463

B01AC07

ATC

dipyridamole; systemic

2.3

7.6

320

R55

ICD-10 Finland

Syncope and collapse

1.8

7.6

128

744

S06.4

ICD-10 Finland

Epidural haemorrhage

25.2

7.6

N99

ICPC

Neurological disease other

6.2

7.6

G72.8

ICD-10 Finland

Other specified myopathies

4.2

7.5

J01MA02

ATC

ciprofloxacin; systemic

1.5

7.5

394

3064

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

7.5

236

1640

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.3

7.4

108

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

3.3

7.4

108

Z98.2

ICD-10 Finland

Presence of cerebrospinal fluid drainage device

80.6

7.4

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

7.3

112

629

I60.6

ICD-10 Finland

Subarachnoid haemorrhage from other intracranial arteries

+∞

7.3

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

+∞

7.3

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

+∞

7.3

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

+∞

7.3

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

9.4

7.3

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

7.3

104

570

X57

ICD-10 Finland

Unspecified privation

3.7

7.1

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.5

7.1

219

XX3XW

NOMESCO Finland

12.1

7.1

A04

ICPC

Weakness/tiredness general

1.8

7.1

124

732

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

10.1

7.0

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

7.0

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

6.4

6.9

W10

ICD-10 Finland

Fall on and from stairs and steps

2.6

6.9

197

N03AX18

ATC

lacosamide; systemic

13.9

6.9

B01AB05

ATC

enoxaparin; parenteral

1.5

6.9

285

2103

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

6.8

148

931

SPAT1360

SPAT

Extensive global examination

2.0

6.8

416

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.8

6.8

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

5.4

6.8

ZXA05

NOMESCO Finland

Left side

1.5

6.8

256

1850

Z43.0

ICD-10 Finland

Attention to tracheostomy

40.3

6.8

G41.0

ICD-10 Finland

Grand mal status epilepticus

40.3

6.8

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

5.0

6.7

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

22.7

6.7

G30.8

ICD-10 Finland

Other Alzheimer disease

3.0

6.6

124

PA6AD

NOMESCO Finland

CT of neck arteries

8.8

6.6

N28

ICPC

Limited function/disability (N)

4.4

6.6

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

6.5

146

927

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

6.5

333

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

6.4

188

1279

T24.3

ICD-10 Finland

Burn of third degree of hip and lower limb, except ankle and foot

70.2

6.4

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.2

6.3

307

A41.9

ICD-10 Finland

Sepsis, unspecified

2.5

6.3

201

J01DB01

ATC

cefalexin; oral

1.4

6.3

708

6271

N88

ICPC

Epilepsy

18.1

6.3

F03

ICD-10 Finland

Unspecified dementia

2.1

6.3

349

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

+∞

6.3

I61.4

ICD-10 Finland

Intracerebral haemorrhage in cerebellum

+∞

6.3

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

+∞

6.3

C03AA03

ATC

hydrochlorothiazide; oral

1.8

6.2

108

635

K78

ICPC

Atrial fibrillation/flutter

1.8

6.2

106

619

N05CD07

ATC

temazepam; oral

1.6

6.2

146

942

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

5.8

6.2

C03CA01

ATC

furosemide; systemic

1.4

6.1

381

3035

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

6.1

172

G40.89

ICD-10 Finland

Other epilepsy

12.6

6.1

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

12.6

6.1

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

12.6

6.1

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

6.1

321

SPAT1252

SPAT

Overall medication plan or its review

1.9

6.0

450

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.2

6.0

R1250

NOMESCO Finland

Evaluation of functional capability

3.6

6.0

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

6.0

126

785

N05AA02

ATC

levomepromazine; systemic

2.7

6.0

149

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3018677) aPTT in Platelet poor plasma by Coagulation assay

323

1254

3.21

62.61

2.3

1.9

30.4

30.2

0.17

314

1211

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

477

2473

2.61

52.05

2.9

2.0

u/l

281.7

289.1

0.04

461

2286

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

8.34

39.08

2.1

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

744

5220

2.26

35.70

7.6

4.8

mmol/l

6.9

0.09

719

4919

(3044640) Blood type and Crossmatch panel - Blood

463

2742

2.17

33.60

3.3

2.6

—

(3032080) INR in Blood by Coagulation assay

602

3953

2.13

33.26

13.9

11.5

inr

1.4

0.04

173

1095

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

142

5.11

31.99

2.2

1.3

e6/l

47.9

66.9

0.14

113

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

142

5.11

31.99

2.3

1.4

e6/l

31173.3

1071.7

0.51

117

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

592

3906

2.09

31.79

5.0

4.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

9.73

29.85

1.8

2.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

281

1420

2.31

29.53

3.2

3.1

mmol/l

0.8

0.10

271

1312

(3023368) Bacteria identified in Blood by Culture

459

2893

1.99

26.57

4.6

4.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

361

2088

2.07

26.56

3.2

2.5

—

(3044290) Cell count panel - Cerebral spinal fluid

111

5.06

25.05

2.2

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

9.86

23.29

2.0

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

535

3678

1.87

22.82

5.2

4.1

ng/l

37.2

60.2

1.32

455

2835

(3036489) Thrombin time

218

3.61

22.14

2.8

2.1

21.0

22.2

0.86

196

(3003396) Base excess in Arterial blood by calculation

225

1156

2.18

22.07

8.5

6.8

mmol/l

1.2

1.3

0.09

174

877

(3016018) Differential panel - Cerebral spinal fluid

6.66

21.83

2.1

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

337

2025

1.95

21.48

5.8

4.1

80.5

83.1

1.08

332

1972

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

221

1152

2.14

20.79

8.6

6.9

kpa

4.9

5.1

1.70

210

1093

(3027801) Oxygen [Partial pressure] in Arterial blood

220

1151

2.13

20.48

8.6

6.9

kpa

13.4

11.6

4.00

209

1092

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

618

4586

1.77

19.25

9.1

7.0

mmol/l

1.2

1.58

531

3856

(3022217) INR in Platelet poor plasma by Coagulation assay

250

1416

1.98

18.58

37.6

30.6

inr

1.7

1.5

0.91

196

(3026008) Bacteria identified in Urine by Culture

416

2784

1.78

18.25

3.6

3.5

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

220

1226

1.99

16.99

8.6

6.7

mmol/l

105.4

104.3

2.63

212

1198

(3020779) Urea [Moles/volume] in Serum or Plasma

173

885

2.13

16.85

6.1

6.6

mmol/l

10.2

11.6

1.64

167

841

(3003458) Phosphate [Moles/volume] in Serum or Plasma

220

1230

1.98

16.82

5.4

5.5

mmol/l

1.0

0.81

209

1135

(3002173) Hemoglobin [Mass/volume] in Arterial blood

179

942

2.07

16.15

9.4

7.6

g/l

116.7

120.3

1.51

174

904

(3016502) Oxygen saturation in Arterial blood

192

1045

2.01

15.77

9.0

7.1

96.7

95.1

6.26

187

1005

(3023183) Ammonium ion [Moles/volume] in Plasma

173

3.42

15.77

2.5

umol/l

28.7

32.9

0.91

139

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

552

4160

1.64

14.67

8.7

6.1

mmol/l

1.2

3.06

498

3722

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

202

3.08

14.04

3.3

2.2

g/l

3.8

3.6

0.23

192

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

590

4572

1.61

13.62

7.6

6.2

umol/l

12.7

0.01

549

4326

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

126

618

2.17

13.57

9.6

8.7

1.4

1.3

0.34

126

613

(3008152) Bicarbonate [Moles/volume] in Arterial blood

129

658

2.09

12.54

9.9

6.0

mmol/l

24.8

24.4

0.63

123

614

(3031040) Bacteria [#/volume] in Urine by Automated count

698

5714

1.58

12.14

6.1

4.8

e6/l

1714.2

2179.8

0.15

108

(3043409) Potassium [Moles/volume] in Arterial blood

321

2.50

12.05

5.8

3.5

mmol/l

3.9

4.0

1.65

298

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

350

2.42

11.74

3.3

2.5

u/ml

0.3

0.10

190

(3020191) Ethanol [Moles/volume] in Serum or Plasma

4.79

10.74

1.7

1.3

promille

1.2

1.0

0.14

(3019309) Folate [Moles/volume] in Red Blood Cells

299

2066

1.61

10.51

2.0

1.8

nmol/l

1178.5

1188.0

0.06

231

1524

(3024354) Oxygen [Partial pressure] in Venous blood

143

807

1.88

10.37

5.1

3.1

kpa

4.8

4.4

0.80

138

782

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

256

1711

1.64

10.26

1.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

267

1805

1.63

10.22

4.7

4.1

ng/l

134.7

323.4

2.67

227

1557

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

123

669

1.94

9.96

4.4

kpa

5.2

0.12

111

612

(3002032) Base excess in Venous blood by calculation

163

973

1.79

9.85

5.7

3.6

mmol/l

1.3

2.1

1.45

131

764

(3009343) pH of Capillary blood

121

659

1.94

9.76

4.4

7.4

0.18

(3023410) Appearance of Cerebral spinal fluid

4.36

9.61

2.2

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

162

979

1.77

9.37

5.8

3.6

kpa

5.7

5.8

0.96

156

946

(3019060) Gas panel - Arterial blood

127

713

1.88

9.34

6.7

3.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

165

1008

1.75

9.19

2.1

1.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

499

3948

1.47

9.09

5.6

4.7

g/l

33.5

34.6

4.15

465

3635

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

510

2.01

9.00

9.6

mmol/l

24.0

24.5

1.06

466

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

438

3392

1.48

8.82

3.8

3.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

113

627

1.89

8.61

4.4

mmol/l

1.4

2.1

0.82

473

(3014111) Lactate [Moles/volume] in Serum or Plasma

144

863

1.77

8.55

9.2

7.1

mmol/l

1.3

1.4

0.35

136

825

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

120

682

1.85

8.49

1.7

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

459

2.00

8.04

2.1

1.8

ug/l

3.4

2.4

0.25

407

(3051593) INR in Capillary blood by Coagulation assay

5.62

8.03

4.0

23.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.22

7.94

1.0

1.1

—

(3042936) Bacteria identified in Isolate by Culture

199

1325

1.61

7.94

2.1

2.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

106

592

1.87

7.92

1.6

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

112

643

1.82

7.67

5.3

3.4

g/l

126.3

126.6

0.03

107

629

(3028626) Oxygen [Partial pressure] in Capillary blood

263

2.27

7.60

4.1

kpa

7.8

0.00

240

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

355

2730

1.44

7.06

3.1

2.5

u/l

60.5

57.3

0.51

329

2503

(3013650) Neutrophils [#/volume] in Blood by Automated count

560

4685

1.39

6.78

10.8

8.6

e9/l

4.4

4.3

0.25

490

4046

(3018010) Neutrophils/100 leukocytes in Blood

463

3760

1.39

6.66

7.1

5.6

59.1

58.6

0.35

428

3478

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

323

2468

1.43

6.58

3.5

3.0

u/l

32.5

35.1

0.64

304

2341

(3000991) Gas panel - Venous blood

132

832

1.66

6.51

9.6

7.9

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

281

2.12

6.50

3.3

3.1

mmol/l

24.8

25.1

0.15

234

(3018418) pH of Serum or Plasma

348

2707

1.41

6.38

4.4

3.9

7.4

0.77

503

(3003694) ABO and Rh group [Type] in Blood

269

1998

1.46

6.34

1.4

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

744

6563

1.40

6.33

9.6

7.5

u/l

84.7

81.2

0.92

697

6109

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

328

2528

1.42

6.33

2.2

mg/l

3.5

3.1

1.52

274

2128

(3013115) Eosinophils [#/volume] in Blood

498

4119

1.38

6.31

7.1

5.5

e9/l

0.2

0.29

439

3562

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

174

1182

1.56

6.31

1.7

1.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

880

8009

1.45

6.17

26.7

17.0

mg/l

26.9

28.2

0.57

790

6497

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

231

1675

1.48

6.15

2.2

1.6

mg/l

2.0

1.5

0.81

187

1326

(3022096) Basophils/100 leukocytes in Blood

447

3669

1.36

5.80

7.1

5.6

0.7

0.6

0.34

414

3391

(3002030) Lymphocytes/100 leukocytes in Blood

465

3842

1.36

5.78

7.5

5.8

25.2

25.9

0.64

427

3532

(3037467) Urinalysis macro (dipstick) panel - Urine

666

5817

1.36

5.73

5.5

4.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

514

1.77

5.72

12.3

9.4

—

(3001604) Monocytes [#/volume] in Blood

478

3971

1.35

5.72

6.6

5.3

e9/l

0.7

0.6

1.31

422

3357

(3006504) Eosinophils/100 leukocytes in Blood

455

3758

1.35

5.63

7.1

5.6

2.9

0.10

418

3471

(3006315) Basophils [#/volume] in Blood

479

3988

1.35

5.62

6.7

5.3

e9/l

0.0

0.78

427

3384

(3015377) Calcium [Moles/volume] in Serum or Plasma

379

3043

1.37

5.61

3.3

3.4

mmol/l

2.3

0.10

326

2586

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

399

1.86

5.56

2.1

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

171

1189

1.52

5.55

4.4

4.0

u/l

243.0

244.6

0.06

160

1108

(3027945) Reticulocytes/100 erythrocytes in Blood

181

1275

1.50

5.53

3.0

2.5

1.8

0.05

159

1118

(3026782) Osmolality of Urine

255

1923

1.42

5.46

3.2

2.9

mosm/kgh2o

531.0

562.4

1.60

217

1634

(42870588) Differential panel, method unspecified - Blood

353

2813

1.37

5.45

7.4

5.5

—

(3019069) Monocytes/100 leukocytes in Blood

455

3773

1.35

5.43

7.4

5.9

9.4

9.1

1.23

419

3500

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

169

1180

1.51

5.38

1.8

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

487

1.76

5.33

5.4

2.8

0.7

0.6

0.88

470

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

278

2137

1.40

5.32

1.7

1.8

pmol/l

418.6

6775183.9

0.80

224

1727

(3001122) Ferritin [Mass/volume] in Serum or Plasma

412

3374

1.35

5.31

3.0

2.8

ug/l

186.6

159.9

0.93

368

3034

(3020891) Body temperature

414

1.82

5.25

6.7

4.5

—

(3023520) Reticulocytes [#/volume] in Blood

143

969

1.55

5.23

3.3

2.7

e9/l

66.5

67.5

0.13

116

764

(3019198) Lymphocytes [#/volume] in Blood

483

4060

1.33

5.19

7.0

5.5

e9/l

1.7

1.9

1.32

436

3518

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

395

3231

1.34

5.08

3.8

3.2

ng/l

1841.1

1859.4

0.04

354

2811

(3047181) Lactate [Moles/volume] in Blood

303

1.93

5.01

8.2

5.3

mmol/l

1.7

1.4

0.82

262

(3027456) Digoxin [Moles/volume] in Serum or Plasma

275

1.97

5.00

2.9

3.1

nmol/l

0.9

0.8

0.52

209

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

437

1.77

4.94

2.3

1.9

—

(3022313) Gas panel - Capillary blood

491

1.72

4.92

4.9

4.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

538

4626

1.31

4.80

4.2

3.1

u/l

73.7

56.7

1.45

491

4181

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

134

913

1.53

4.78

2.8

2.6

ug/l

3.8

6.0

3.18

117

789

(3002582) Erythrocytes [#/volume] in Urine

353

2865

1.34

4.72

4.1

3.5

e6/l

72.2

83.1

0.13

301

2294

(3000850) Epithelial cells [#/volume] in Urine

263

2044

1.37

4.65

3.2

2.6

e6/l

3.7

4.2

0.39

235

1798

(3021901) Oxygen saturation in Capillary blood

207

2.07

4.58

2.9

2.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

192

1422

1.42

4.49

2.8

2.6

g/l

2.2

0.39

172

1309

(3045142) Bone marrow Pathology biopsy report

111

2.47

4.49

1.3

—

(4268621)

3.23

4.34

2.8

2.1

—

(3019150) Specific gravity of Urine by Refractometry

235

1815

1.37

4.29

5.7

4.2

kg/l

1.0

1.17

281

(3018095) Leukocytes [#/volume] in Urine

387

3218

1.31

4.28

4.7

3.9

e6/l

67.7

130.7

1.38

313

2430

(3021960) Folate [Moles/volume] in Serum or Plasma

299

2406

1.33

4.16

1.8

1.6

nmol/l

19.6

19.8

0.05

257

2014

(3024928) Oxygen saturation in Venous blood

202

2.02

4.11

8.6

2.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

415

1.71

4.11

7.4

4.3

0.8

0.9

0.81

387

(3030981) Hyaline casts [#/volume] in Urine by Automated count

565

1.60

4.08

3.5

2.7

e6/l

0.6

0.4

0.46

554

(3011648) Oxygen content in Venous blood

2.84

3.97

15.9

2.5

11.9

10.8

0.40

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

404

1.70

3.96

5.6

5.2

mmol/l

24.3

25.0

1.20

377

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

314

1.79

3.93

1.4

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

421

1.68

3.91

7.4

4.3

1.5

1.6

0.26

394

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2.48

3.90

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

7.32

3.86

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

6.04

3.82

1.1

—

(40761535) Cells panel - Urine sediment

113

782

1.49

3.77

3.5

3.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

12.05

3.76

1.0

1.4

—

(36304419) Bacteria [Presence] in Urine

301

2459

1.31

3.71

3.8

3.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

196

1.97

3.71

1.3

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

5.66

3.66

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

5.66

3.66

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.66

3.66

1.1

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

5.66

3.66

1.1

1.3

—

(40758558) Short blood count panel - Blood

249

1989

1.32

3.60

7.5

6.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

902

8467

1.33

3.55

31.3

20.5

mmol/l

139.5

139.6

0.89

884

8210

(3022948) Iron [Moles/volume] in Serum or Plasma

201

1560

1.35

3.53

2.8

2.6

umol/l

12.3

12.0

0.22

182

1430

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

178

1357

1.37

3.50

2.9

2.6

22.1

21.9

0.03

152

1148

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

10.04

3.50

1.2

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.36

3.48

1.0

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

663

1.51

3.45

2.0

2.2

nmol/l

353.3

369.2

0.41

596

(3029937) Albumin [Presence] in Urine by Test strip

278

2267

1.30

3.45

5.2

4.2

estimate

0.0

0.50

733

(3023103) Potassium [Moles/volume] in Serum or Plasma

902

8479

1.32

3.43

31.2

20.6

mmol/l

4.0

0.32

883

8217

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

452

3919

1.26

3.40

2.4

2.1

pmol/l

88.9

92.1

0.81

276

2098

(3003181) Sodium [Moles/volume] in Urine

175

1.97

3.36

1.6

1.3

mmol/l

66.1

65.0

0.05

145

(3011397) Hemoglobin [Presence] in Urine by Test strip

234

1875

1.31

3.29

4.9

3.8

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

149

2.04

3.27

1.2

—

(3019230) Fractional oxyhemoglobin in Venous blood

163

1.99

3.26

10.3

2.3

64.2

62.0

0.19

163

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

8.61

3.26

1.2

1.4

—

(4034850)

272

1.76

3.26

11.2

13.7

—

(3035350) Ketones [Presence] in Urine by Test strip

464

4050

1.25

3.26

5.0

3.9

estimate

0.0

0.00

777

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

130

952

1.41

3.25

3.6

2.6

umol/l

8.1

10.1

1.09

117

844

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.69

3.23

1.8

1.3

—

(1761868) Lipid panel - Serum or Plasma

178

2264

0.75

3.20

3.3

3.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

152

1147

1.38

3.18

10.3

8.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.65

3.14

1.8

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

119

2.13

3.06

1.2

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

2.52

3.05

1.8

1.1

u/ml

8.2

2.9

0.56

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

100

707

1.45

3.03

3.5

3.9

ng/l

109.4

99.8

0.46

610

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

113

2.15

3.02

1.1

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

465

4085

1.24

3.01

5.1

3.9

estimate

0.0

0.50

756

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

366

3132

1.25

3.01

5.5

4.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

382

3286

1.25

3.00

2.4

2.2

nmol/l

75.7

78.7

1.19

336

2825

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

273

1.71

2.95

1.8

—

(3030467) Casts [#/volume] in Urine by Automated count

309

2600

1.26

2.94

3.8

3.4

e6/l

0.6

0.5

0.36

257

2035

(3021601) Nitrite [Presence] in Urine by Test strip

458

4026

1.23

2.93

6.8

5.3

estimate

0.0

0.00

773

(3003338) MCHC [Mass/volume]

685

6298

1.22

2.76

32.7

22.5

g/l

330.9

331.6

0.97

677

6230

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

529

1.49

2.72

1.8

1.9

g/l

1.5

0.18

462

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

664

1.44

2.70

1.9

1.7

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

4.23

2.68

12.4

15.7

nmol/l

1112.6

1443.7

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

4.23

2.68

8.4

12.6

nmol/l

624.8

833.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

192

1.79

2.60

1.7

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

387

1.55

2.59

1.3

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

208

1.75

2.56

1.4

1.8

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

629

1.43

2.55

2.1

1.7

1.8

1.6

1.24

522

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

7.17

2.55

1.2

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

2.44

2.54

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2.44

2.54

2.5

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

5.48

2.54

1.7

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.48

2.54

1.7

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

101

2.10

2.54

1.0

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

101

2.10

2.54

3.3

2.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.62

2.53

2.3

2.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.62

2.53

1.8

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.05

2.53

1.3

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.05

2.53

1.3

2.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

657

1.42

2.50

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

615

1.43

2.49

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

2.21

2.48

2.3

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

565

1.45

2.48

3.1

2.9

g/l

11.5

10.9

0.42

516

(3028707) Methadone [Presence] in Urine by Screen method

2.84

2.48

2.2

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.40

2.47

1.0

1.3

—

(3018572) Chloride [Moles/volume] in Blood

218

1.72

2.47

10.2

5.6

mmol/l

106.8

105.1

1.37

193

(3039000) Anion gap in Blood

218

1.72

2.47

10.2

5.6

mmol/l

11.0

11.5

0.46

193

(3052592) Norovirus Ag [Presence] in Stool

3.83

2.46

1.1

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.35

2.39

1.0

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

228

1.69

2.39

1.8

2.3

g/l

129.4

127.7

0.16

169

(3020630) Protein [Mass/volume] in Serum or Plasma

116

881

1.35

2.37

3.0

2.7

g/l

65.7

65.9

0.11

105

789

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.63

2.36

1.9

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.63

2.36

1.9

1.3

—

(3027944) Amphetamines [Presence] in Urine

2.16

2.35

1.9

1.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

655

6052

1.20

2.31

4.6

4.1

mm/h

16.5

14.5

1.78

602

5466

(3014271) Vancomycin [Susceptibility]

2.39

2.30

4.6

2.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

729

1.38

2.28

3.0

2.5

—

(3011288) Drugs identified in Urine by Screen method

2.47

2.28

4.2

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

130

1011

1.32

2.27

3.8

—

(40761511) CBC panel - Blood by Automated count

863

8191

1.23

2.27

24.2

16.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

106

2.00

2.26

1.0

1.2

u/ml

246.0

294.2

0.40

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

185

1509

1.27

2.26

3.4

3.2

e6/l

2.0

1.9

0.06

116

897

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

295

1.58

2.25

1.5

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

689

1.38

2.23

3.5

3.1

ml/min/173m2

55.5

58.0

0.22

297

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

5.57

2.21

1.0

1.1

—

(3012501) Base excess in Blood by calculation

221

1.65

2.11

3.3

4.8

mmol/l

2.4

2.6

0.16

153

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.72

2.10

2.2

1.4

umol/l

65.4

62.5

—

(4198724)

5.02

2.07

1.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

103

1.96

2.06

2.5

2.0

—

(3019225) pH of Specimen

122

955

1.31

2.05

6.1

4.6

—

(21494434) Karyotype in Bone marrow

111

1.91

2.01

1.2

—

(3010421) pH of Blood

272

1.57

2.00

3.4

4.4

7.4

0.07

217

(3028026) IgM [Mass/volume] in Serum or Plasma

462

1.43

1.99

2.0

1.9

g/l

1.0

1.7

2.46

421

(3022621) pH of Urine by Test strip

590

1.38

1.99

4.0

3.1

—

(3016879) Cocaine [Presence] in Urine

2.09

1.97

2.4

1.2

—

(3028300) Cannabinoids [Presence] in Urine

2.04

1.96

2.4

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.95

1.96

1.9

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

165

1.71

1.92

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.26

1.91

2.2

2.9

—

(40767503) Oxygen content in Capillary blood by calculation

221

1.60

1.87

2.3

2.6

16.3

15.6

0.69

116

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.87

1.86

2.0

1.6

—

(1616796) Gas panel - Central venous blood

237

1.58

1.86

3.0

3.8

—

(3024471) HLA-A [Type]

3.54

1.84

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.54

1.84

1.5

2.0

—

(3024932) HLA-DR beta [Type]

3.54

1.84

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

238

1.57

1.83

1.7

1.4

ug/g

269.4

262.8

0.07

143

(3004809) Band form neutrophils/100 leukocytes in Blood

186

1.63

1.73

3.4

3.9

1.7

1.6

0.07

142

(3037522) Nuclear Ab [Titer] in Serum

109

862

1.29

1.73

1.3

titre

408.0

461.2

0.19

185

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

188

1586

1.22

1.72

3.2

3.0

e6/l

1.0

1.1

0.20

118

968

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.86

1.71

1.0

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

148

1.70

1.71

1.4

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

333

1.46

1.70

2.3

2.5

g/l

0.6

1.5

1.78

278

(3010813) Leukocytes [#/volume] in Blood

906

8718

1.20

1.67

37.3

24.9

e9/l

7.1

6.9

2.05

881

8372

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

877

8417

1.19

1.65

13.9

10.9

u/l

25.1

24.7

0.26

838

8004

(3007461) Platelets [#/volume] in Blood

905

8714

1.20

1.62

37.3

24.9

e9/l

229.7

235.7

1.76

880

8407

(3035941) MCH [Entitic mass]

905

8715

1.20

1.62

37.1

24.8

30.5

0.10

888

8509

(3024731) MCV [Entitic volume]

905

8715

1.20

1.62

37.2

24.8

92.0

91.8

0.49

888

8510

(3042733) HLA Ab [Presence] in Serum

3.58

1.61

3.0

5.1

—

(3026361) Erythrocytes [#/volume] in Blood

905

8716

1.20

1.61

37.3

24.9

e12/l

4.3

4.4

7.33

880

8374

(3027008) Opiates [Presence] in Urine

1.92

1.60

2.4

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

2.08

1.60

1.1

1.0

ng/l

177.8

312.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

2.08

1.60

1.1

1.0

ng/l

411.8

634.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

2.08

1.60

1.1

1.0

ng/l

26.8

44.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

905

8718

1.20

1.60

37.6

25.1

g/l

129.4

133.0

8.93

889

8509

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.70

1.58

1.3

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.60

1.51

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

2.17

1.51

1.4

1.2

—

(40768446) Kidney Pathology biopsy report

2.87

1.50

1.2

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

284

1.46

1.49

1.9

2.2

g/l

0.0

1.35

258

(3049717) Cytology report of Urine Cyto stain

481

1.35

1.48

3.0

2.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.51

1.45

2.3

2.8

—

(3033799) Differential panel - Peritoneal fluid

2.74

1.43

2.3

2.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

712

0.73

1.43

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

149

1.62

1.42

2.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.95

1.36

1.4

1.0

miu/ml

1646.4

1307.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

205

1786

1.18

1.34

3.1

mmol/l

2.5

0.27

183

1548

(21494755) Public health laboratory ask at order entry panel

271

0.58

1.33

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

353

1.38

1.29

4.3

3.5

mg/l

48.2

74.2

0.77

289

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

345

1.38

1.28

4.2

3.5

ratio

2.5

2.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.75

1.25

1.1

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

364

1.36

1.25

1.8

2.4

g/l

3.3

3.2

0.26

282

(3008757) Leukocyte morphology finding [Identifier] in Blood

123

1.64

1.24

4.2

5.0

—

(3028433) Virus identified in Specimen by Culture

2.41

1.24

1.0

1.6

—

(3048879) Bone marrow aspiration report

2.23

1.24

1.6

1.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

265

2372

1.15

1.23

3.8

2.9

umol/l

374.5

7820.4

9.52

219

1999

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1.97

1.22

2.8

3.3

u/ml

44.6

39.5

0.08

(3022689) Creatine [Moles/volume] in Urine

2.64

1.21

1.2

1.4

—

(3023419) Bacteria identified in Sputum by Culture

132

1.60

1.21

3.2

2.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1.75

1.19

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

125

1.61

1.18

3.8

3.9

62.0

55.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1.86

1.13

1.2

1.1

114.6

108.4

0.22

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

397

1.32

1.13

1.7

2.3

g/l

4.1

3.8

0.51

275

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

748

7175

1.13

1.12

4.8

4.4

mu/l

2.1

0.10

667

6333

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

398

1.32

1.11

1.7

2.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1.97

1.11

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.27

1.10

3.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

399

1.32

1.10

1.7

2.3

g/l

7.4

7.5

0.06

286

(44816559) Phosphatidylethanol [Mass/volume] in Blood

104

1.64

1.09

2.4

1.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.39

1.09

6.8

2.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

778

1.23

1.09

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

304

1.36

1.08

1.9

2.1

g/l

37.6

37.1

0.21

254

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.19

1.08

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.19

1.08

1.0

—

(3025130) Human papilloma virus identified in Specimen

2.13

1.05

1.4

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

254

1.39

1.05

4.0

3.5

—

(4306422)

1.80

1.05

1.3

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.28

1.03

5.8

2.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

388

1.30

0.99

3.2

2.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

258

1.37

0.98

1.9

2.4

ug/min

129.9

95.1

0.24

152

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

354

1.31

0.97

4.4

3.6

mg/l

34.1

78.2

0.71

294

(40760892) CBC W Ordered Manual Differential panel - Blood

183

1628

1.15

0.94

5.2

4.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

144

0.55

0.93

1.8

1.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

269

1.35

0.93

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.74

0.92

1.6

1.5

—

73.4

—

(3021589) Normoblasts [#/volume] in Blood

381

3554

1.11

0.90

13.3

10.4

e9/l

0.0

0.49

318

2889

(3044889) 12 lead EKG panel

617

5899

1.10

0.88

4.7

4.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.91

0.88

1.1

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.91

0.88

5.8

6.6

64.3

74.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

101

863

1.19

0.87

2.9

2.1

g/l

0.2

0.16

800

(4094501)

192

0.62

0.86

1.2

1.1

—

(3045716) Anion gap in Serum or Plasma

1.82

0.86

1.5

1.8

mmol/l

8.3

9.6

—

(3004616) Nuclear Ab [Presence] in Serum

1.60

0.84

1.3

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.94

0.84

1.2

1.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.94

0.84

4.2

1.7

u/ml

800.5

1733.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

403

3782

1.10

0.84

2.6

2.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

775

7505

1.11

0.83

6.8

6.5

mmol/mol

41.7

41.0

1.10

704

6775

(1761482) Bacteria [#/volume] in Urine by Culture

311

1.30

0.82

4.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.55

0.81

1.0

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.55

0.81

1.3

1.9

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.61

0.81

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

242

1.33

0.79

1.4

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.79

0.0

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.82

0.79

1.3

1.6

—

(3047189) Immunofixation for 24 hour Urine

1.67

0.79

2.3

1.5

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

0.00

0.77

0.0

1.1

—

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

337

0.74

0.77

1.6

1.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

157

1.41

0.77

1.5

1.3

e6/l

14248.4

111415.8

1.46

(3041918) Cholesterol [Moles/volume] in Pleural fluid

0.00

0.76

0.0

1.1

—

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.70

0.75

1.7

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.70

0.75

1.7

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1.65

0.75

1.3

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.09

0.74

1.2

1.0

iu/ml

194.6

163.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

767

7443

1.10

0.74

23.9

16.3

ml/min/173m2

70.4

72.1

1.27

665

6164

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

794

0.83

0.73

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

237

2181

1.11

0.73

4.8

3.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.00

0.72

2.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1.80

0.72

1.1

1.3

nmol/l

0.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.53

0.72

1.4

1.9

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

117

1.46

0.72

1.6

1.4

—

(40765096) Chromosome analysis panel by Banding

1.75

0.71

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.93

0.70

2.0

1.5

—

(3044007) Cell count panel - Peritoneal fluid

1.93

0.70

2.6

1.7

—

(3025941) Bacteria identified in Stool by Culture

391

1.24

0.70

1.3

1.2

—

(4211845)

1.71

0.70

3.7

3.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

374

1.24

0.69

1.8

2.3

g/l

11.0

10.4

0.35

313

(3020682) Albumin/Creatinine [Ratio] in Urine

320

2998

1.09

0.68

4.1

4.0

mg/mmol

13.6

8.8

0.95

230

1952

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

311

1.26

0.68

1.8

2.0

u/l

37.3

37.9

0.07

265

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

772

1.17

0.68

4.4

3.8

mmol/l

1.2

0.67

664

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

127

1.42

0.68

2.9

3.5

—

2769.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

119

1.44

0.67

1.6

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

119

1.44

0.67

1.6

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

119

1.44

0.67

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

119

1.44

0.67

1.6

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.63

0.67

1.6

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.63

0.67

1.4

mmol/l

2.3

3.9

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.79

0.66

1.0

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

145

1.39

0.66

4.2

2.8

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.58

0.65

1.1

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

120

1.42

0.64

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

120

1.42

0.64

1.6

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

172

1.34

0.64

1.1

1.4

—

(3037756) Immunofixation for Serum or Plasma

243

1.28

0.63

1.7

1.6

—

(3000492) Spirometry study

641

0.83

0.62

1.6

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

208

1.31

0.62

1.4

—

(3013512) EKG study

296

2778

1.09

0.61

5.8

4.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1085

0.87

0.61

1.2

u/ml

15.0

13.8

0.06

377

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

1.57

0.60

1.3

1.1

—

11.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.57

0.60

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

174

1.33

0.60

1.6

1.4

e6/l

743.2

1731.3

2.50

127

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

0.00

0.60

0.0

1.1

—

20.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

0.00

0.60

0.0

1.4

—

5.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

0.00

0.60

0.0

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

747

7274

1.08

0.59

4.1

mmol/l

1.3

0.52

669

6397

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

140

1.36

0.58

1.1

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

364

1.22

0.58

2.8

3.1

pmol/l

4.3

4.4

0.16

312

(3017569) Oxygen content in Arterial blood

1.48

0.57

2.8

3.2

—

(3044941) Cell count panel - Synovial fluid

132

1.37

0.57

1.1

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

149

0.67

0.57

1.6

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

229

0.74

0.56

1.2

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.62

0.55

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

1.62

0.55

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

1.62

0.55

4.2

3.5

—

(3002256) Pathology report gross observation

125

1130

1.12

0.55

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

148

0.67

0.55

1.0

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

122

0.65

0.55

1.6

1.9

pmol/l

223.5

229.3

—

113

(3021788) Differential panel - Synovial fluid

160

1.32

0.53

1.2

1.5

—

(40768441) Liver Pathology biopsy report

1.48

0.53

1.3

1.1

—

(4146454)

108

1.39

0.53

2.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

178

1.30

0.53

1.4

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.50

0.51

1.0

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.50

0.51

1.0

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

247

0.77

0.50

1.7

—

(3017732) Neutrophils [#/volume] in Blood

511

1.16

0.50

2.9

3.2

e9/l

3.5

4.1

1.30

373

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

107

966

1.12

0.50

3.4

3.1

ng/l

336.7

249.0

0.58

101

888

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

596

5782

1.07

0.49

4.0

3.6

pmol/l

15.1

0.02

535

5093

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1.56

0.49

1.4

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

1.52

0.48

1.0

1.1

nmol/l

190.9

139.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

181

1.28

0.48

1.5

1.2

u/ml

3.3

7.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.49

0.47

1.0

1.3

u/l

213.4

480.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

192

2055

0.92

0.47

1.7

1.6

mmol/l

1.4

1.3

0.47

155

1672

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1.39

0.46

1.5

1.2

nmol/l

0.7

0.6

0.20

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.60

0.45

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.40

0.44

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

1.37

0.44

1.2

1.4

u/l

16.6

14.3

0.46

(3012516) Albumin [Mass/volume] in Urine

297

2827

1.07

0.43

3.3

mg/l

269.4

239.5

0.05

212

1862

(3034770) Mitochondria Ab [Titer] in Serum

193

1.25

0.43

1.3

1.2

—

752.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1.38

0.42

1.6

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

1.38

0.42

1.7

1.6

—

(4027681)

1.56

0.42

1.0

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

301

2871

1.07

0.41

3.4

3.2

mmol/l

7.2

7.4

0.29

250

2355

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.38

0.41

1.5

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.41

0.0

1.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.00

0.40

0.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

0.00

0.40

0.0

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.5

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

149

0.74

0.40

3.6

3.1

e9/l

4.4

4.5

0.05

149

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

270

0.81

0.39

1.7

1.8

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1.31

0.39

3.0

2.4

—

(3025159) Blasts/100 leukocytes in Blood

664

0.88

0.39

5.1

4.3

0.3

0.6

0.30

198

(3003327) Ova and parasites identified in Stool by Light microscopy

178

1.24

0.39

1.4

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.39

0.38

1.0

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

206

1.22

0.38

1.3

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.35

0.38

1.5

1.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

450

4357

1.05

0.37

5.5

5.7

ug/l

8.5

4.5

0.39

400

3824

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

225

1.20

0.37

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

106

1149

0.91

0.36

1.2

1.3

iu/ml

66.3

39.6

0.56

349

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

366

1.15

0.36

4.3

3.2

u/ml

337.3

4548.5

0.86

308

(4010399)

617

0.89

0.36

1.3

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.66

0.35

1.4

1.1

—

(3000330) Specific gravity of Urine by Test strip

528

1.12

0.35

4.3

3.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.37

0.34

1.4

1.2

—

(3012441) Differential panel - Pleural fluid

145

1.25

0.34

1.3

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

145

1.25

0.34

1.4

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

136

1274

1.08

0.33

1.6

1.5

g/l

3.0

2.7

0.67

726

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

210

1.19

0.33

1.6

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

210

1.19

0.33

1.6

1.3

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

1.28

0.32

2.3

3.7

nmol/l

105.7

115.3

—

(3024263) Appearance of Synovial fluid

1.28

0.32

1.0

1.4

—

(40768806) Pleura Pathology biopsy report

146

1.24

0.32

1.2

1.6

—

(4035726)

763

1.09

0.31

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

156

1.22

0.31

1.1

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.32

0.31

3.3

3.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

438

1.12

0.30

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

577

0.90

0.30

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

152

0.79

0.29

3.7

3.5

60.0

59.2

0.11

152

(40768793) Breast Pathology biopsy report

130

0.77

0.29

1.4

1.3

—

(36660697) Celiac disease serology panel - Serum

497

1.11

0.29

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.23

0.29

2.4

3.8

—

(1002224) Polysomnography panel

186

1.19

0.28

1.0

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

233

1.16

0.27

1.4

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

177

1.19

0.27

1.0

1.1

—

6.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.23

0.27

1.4

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

246

0.85

0.26

1.2

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

141

1.21

0.26

1.4

1.5

iu/l

2.6

6.4

—

(40768797) Stomach Pathology biopsy report

118

1112

1.07

0.26

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

361

3508

1.04

0.26

4.8

4.9

23.3

22.0

0.93

196

1897

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

330

1.13

0.25

1.1

1.2

iu/ml

93.4

147.2

0.65

114

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

319

0.87

0.25

1.5

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.20

0.25

1.0

1.1

—

(3008898) HLA-B27 [Presence]

148

0.81

0.24

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

297

0.87

0.24

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.32

0.23

1.2

1.4

g/l

1.0

—

(40768804) Tissue Pathology biopsy report

338

3291

1.04

0.22

2.4

2.3

—

(44806420)

1.22

0.22

1.8

2.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.22

0.22

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.22

0.22

1.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.21

0.0

1.8

—

0.8

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

787

7783

1.04

0.21

5.1

mmol/l

6.2

6.1

0.67

694

6871

(3042631) Mycobacterium sp identified in Specimen

154

1.17

0.21

2.1

2.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

491

0.91

0.21

3.0

2.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.16

0.21

1.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.21

0.0

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.21

0.0

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

282

0.88

0.20

1.0

1.1

—

207.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.20

0.0

1.0

—

10.0

—

(40761536) Microorganisms panel - Urine sediment

737

0.93

0.20

4.7

4.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

111

0.81

0.20

2.8

3.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.13

0.18

1.2

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

164

0.85

0.18

1.1

1.5

nmol/l

1.6

0.8

—

136

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

100

1.20

0.18

1.1

1.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

214

1.12

0.17

1.3

1.6

e6/l

21310.0

19266.6

0.09

151

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.13

0.17

1.3

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

205

0.88

0.17

1.4

1.2

—

(3005570) Glucose [Moles/volume] in Urine

110

1.18

0.17

1.2

2.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

225

1.11

0.16

1.5

iu/ml

0.2

24.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.13

0.16

1.1

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.11

0.16

1.3

2.0

—

(40768795) Lymph node Pathology biopsy report

1.11

0.16

1.4

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

0.78

0.15

1.0

—

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

265

0.90

0.15

1.3

1.2

—

(3022145) Colonoscopy Study observation

880

1.05

0.15

1.4

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

643

6361

1.03

0.15

30.4

20.5

14.2

13.9

3.96

635

6202

(3037121) Protein [Mass/volume] in Urine

362

1.08

0.14

2.7

3.3

g/l

0.3

0.03

143

(3009542) Hematocrit [Volume Fraction] of Blood

696

6900

1.02

0.12

27.9

18.2

38.1

38.7

0.67

393

4158

(3045788) Cell count panel - Pleural fluid

133

1.13

0.12

1.5

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

143

1.12

0.11

1.2

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

768

7629

1.02

0.11

4.6

mmol/l

4.2

4.4

8.61

695

6834

(40760888) Immunoglobulin light chains.free panel - Serum

270

1.08

0.10

5.5

3.8

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

166

0.90

0.09

1.7

nmol/l

45.6

42.2

0.34

156

(3048689) Calprotectin [Mass/mass] in Stool

733

1.04

0.09

2.3

2.2

ug/g

136.1

156.6

0.29

564

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

756

0.96

0.09

3.6

2.6

u/l

30.2

32.5

0.41

634

(3000012) Reticulocyte production index

0.82

0.08

4.4

1.8

—

(3017181) Myelocytes/100 leukocytes in Blood

754

0.97

0.08

4.9

4.2

1.4

0.8

0.80

252

(3035637) Corticotropin [Mass/volume] in Plasma

1.14

0.08

1.1

1.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.14

0.08

1.7

1.2

nmol/l

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

1.08

0.08

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

789

7852

1.02

0.08

5.1

5.2

mmol/l

2.4

2.6

8.07

706

6991

(4024509)

0.83

0.07

1.7

1.5

—

(3035880) pH of Pleural fluid

0.83

0.07

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

206

1.07

0.07

1.3

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.05

0.07

1.3

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1.03

0.07

1.2

1.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

132

0.91

0.06

1.4

mmol/l

7.1

6.3

0.47

124

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

148

1.08

0.06

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

108

1058

1.02

0.06

4.2

4.0

ug/l

54.5

33.1

0.25

896

(3014765) Yersinia sp identified in Stool by Organism specific culture

207

1.06

0.06

1.3

1.1

—

(3000494) Fungus identified in Specimen by Culture

969

1.02

0.06

1.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

100

1.10

0.05

2.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

218

1.06

0.05

3.1

3.5

mg/l

28.2

30.5

0.10

140

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

242

0.95

0.05

1.3

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

706

0.98

0.04

4.8

4.3

0.1

0.18

231

(3044927) Protein electrophoresis panel - Urine

130

1.08

0.04

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

209

1.05

0.04

1.3

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

139

1408

0.99

0.04

1.2

u/ml

0.8

1.2

0.85

338

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

121

1.08

0.03

1.9

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

109

1099

0.99

0.01

5.0

4.7

33.4

32.6

0.25

692

(3014051) Protein [Presence] in Urine by Test strip

203

1.04

0.01

2.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

668

0.99

0.01

2.2

nmol/l

12.6

12.0

0.17

571

(3002179) Metamyelocytes/100 leukocytes in Blood

673

1.01

0.01

4.5

4.1

1.2

0.5

0.56

186

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

244

1.03

0.00

1.3

1.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

1.04

0.00

1.4

84.6

68.5

—

(44790049)

106

1.04

0.00

1.2

1.6

—

(44790048)

106

1.04

0.00

1.2

1.6

—

(44790047)

106

1.04

0.00

1.2

1.6

—

(44806118)

106

1.04

0.00

1.2

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

114

0.96

0.00

1.3

—

(3045424) Erythrocytes [Presence] in Urine

126

1.03

0.00

1.4

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

188

1.01

0.00

1.4

1.6

mg/l

3.0

3.2

0.04

147

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

141

0.99

0.00

1.3

1.6

—

(40768443) Skin Pathology biopsy report

371

1.00

0.00

1.1

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

247

2471

1.00

0.00

3.4

ug/l

1.2

0.8

1.24

171

1775

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

117

1.03

0.00

3.1

2.3

u/ml

3.2

381.5

0.56

112

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

143

0.98

0.00

1.4

1.3

—

(3045414) Leukocytes [Presence] in Urine

363

0.99

0.00

2.0

1.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1.05

0.00

1.5

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

115

1.04

0.00

1.3

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1.05

0.00

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1.05

0.00

1.5

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

2.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.7

—

(4281824)

0.89

0.00

1.3

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.88

0.00

1.2

1.6

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.0

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.0

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.91

0.00

1.1

1.7

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

4.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

0.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

3.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.89

0.00

1.8

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.89

0.00

1.8

1.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.0

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

0.90

0.00

3.1

3.2

—

(3004451) EKG impression Narrative

0.86

0.00

1.4

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.0

1.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

753

7530

1.00

0.00

4.6

mmol/l

1.3

1.4

6.36

672

6681

(3051651) Icteric interference index of Serum or Plasma

1.02

0.00

3.4

3.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.89

0.00

1.2

1.6

—

(3026480) Teichoate Ab [Titer] in Serum

0.00

0.0

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

23.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.89

0.00

1.8

1.7

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(4062490)

0.89

0.00

1.8

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.0

6.7

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

0.89

0.00

1.2

1.3

—

60.0

—

(3016750) Collection duration of Urine

1.00

0.00

3.0

2.2

min

479.5

501.8

—

(3013762) Body weight Measured

0.00

0.0

1.8

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

0.00

0.0

1.1

—

78.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.7

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.0

8.7

—

35.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.89

0.00

1.8

1.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_OTHINTRACRA and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_OTHINTRACRA	2.148 [1.85, 2.49]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.346

During the follow-up period (1.1.1998 — 31.12.2019), 1445 out of 2816 females with I9_OTHINTRACRA died.

Males

Parameter	HR [95% CI]	p-value
I9_OTHINTRACRA	2.024 [1.74, 2.35]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 2569 out of 4843 males with I9_OTHINTRACRA died.

Mortality risk

Mortality risk for people of age

years, who have I9_OTHINTRACRA.

N-year risk	Females	Males
1	0.205%	0.342%
5	1.286%	2.021%
10	3.13%	5.194%
15	6.112%	10.143%
20	10.484%	17.079%

Relationships between endpoints

↥

Index endpoint: I9_OTHINTRACRA – Other intracranial haemorrhages

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other intracranial haemorrhages

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints